Evoke Pharma's total assets for Q2 2025 were $16.06M, a decrease of -1.93% from the previous quarter. EVOK total liabilities were $11.69M for the fiscal quarter, a 10.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.